歌舞伎座の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/03/11 | 5,280 | 5,340 | 5,280 | 5,320 | +30 | +0.6% | 4,100 |
2020/03/10 | 5,390 | 5,390 | 5,230 | 5,290 | -100 | -1.9% | 9,000 |
2020/03/09 | 5,600 | 5,600 | 5,350 | 5,390 | -190 | -3.4% | 13,000 |
2020/03/06 | 5,600 | 5,600 | 5,500 | 5,580 | -50 | -0.9% | 1,400 |
2020/03/05 | 5,510 | 5,630 | 5,500 | 5,630 | +130 | +2.4% | 3,100 |
2020/03/04 | 5,490 | 5,540 | 5,490 | 5,500 | -50 | -0.9% | 1,500 |
2020/03/03 | 5,680 | 5,680 | 5,500 | 5,550 | -10 | -0.2% | 7,100 |
2020/03/02 | 5,350 | 5,650 | 5,350 | 5,560 | +30 | +0.5% | 6,000 |
2020/02/28 | 5,700 | 5,700 | 5,370 | 5,530 | -200 | -3.5% | 14,300 |
2020/02/27 | 5,720 | 5,760 | 5,720 | 5,730 | -70 | -1.2% | 7,900 |
2020/02/26 | 5,810 | 5,860 | 5,800 | 5,800 | -30 | -0.5% | 5,000 |
2020/02/25 | 5,820 | 5,860 | 5,810 | 5,830 | -40 | -0.7% | 10,500 |
2020/02/21 | 5,830 | 5,870 | 5,830 | 5,870 | +40 | +0.7% | 6,200 |
2020/02/20 | 5,830 | 5,860 | 5,810 | 5,830 | ±0 | ±0% | 6,200 |
2020/02/19 | 5,800 | 5,830 | 5,790 | 5,830 | +30 | +0.5% | 7,300 |
2020/02/18 | 5,800 | 5,800 | 5,790 | 5,800 | ±0 | ±0% | 3,500 |
2020/02/17 | 5,820 | 5,830 | 5,800 | 5,800 | -20 | -0.3% | 3,600 |
2020/02/14 | 5,830 | 5,830 | 5,810 | 5,820 | -10 | -0.2% | 5,500 |
2020/02/13 | 5,820 | 5,830 | 5,820 | 5,830 | ±0 | ±0% | 300 |
2020/02/12 | 5,810 | 5,830 | 5,810 | 5,830 | +10 | +0.2% | 1,900 |
2020/02/10 | 5,820 | 5,820 | 5,810 | 5,820 | ±0 | ±0% | 2,400 |
2020/02/07 | 5,810 | 5,820 | 5,800 | 5,820 | ±0 | ±0% | 1,300 |
2020/02/06 | 5,820 | 5,820 | 5,800 | 5,820 | ±0 | ±0% | 3,500 |
2020/02/05 | 5,810 | 5,820 | 5,810 | 5,820 | +10 | +0.2% | 400 |
2020/02/04 | 5,810 | 5,830 | 5,810 | 5,810 | ±0 | ±0% | 2,700 |
2020/02/03 | 5,810 | 5,830 | 5,810 | 5,810 | ±0 | ±0% | 2,700 |
2020/01/31 | 5,810 | 5,820 | 5,810 | 5,810 | ±0 | ±0% | 4,700 |
2020/01/30 | 5,810 | 5,820 | 5,810 | 5,810 | -10 | -0.2% | 3,500 |
2020/01/29 | 5,830 | 5,830 | 5,820 | 5,820 | -10 | -0.2% | 1,500 |
2020/01/28 | 5,810 | 5,830 | 5,810 | 5,830 | ±0 | ±0% | 2,500 |
2020/01/27 | 5,830 | 5,830 | 5,820 | 5,830 | +10 | +0.2% | 2,100 |
2020/01/24 | 5,820 | 5,830 | 5,820 | 5,820 | ±0 | ±0% | 1,900 |
2020/01/23 | 5,820 | 5,830 | 5,810 | 5,820 | ±0 | ±0% | 6,600 |
2020/01/22 | 5,830 | 5,830 | 5,810 | 5,820 | ±0 | ±0% | 2,400 |
2020/01/21 | 5,820 | 5,820 | 5,820 | 5,820 | +10 | +0.2% | 600 |
2020/01/20 | 5,820 | 5,830 | 5,810 | 5,810 | -20 | -0.3% | 3,900 |
2020/01/17 | 5,820 | 5,830 | 5,820 | 5,830 | +10 | +0.2% | 600 |
2020/01/16 | 5,830 | 5,830 | 5,820 | 5,820 | ±0 | ±0% | 1,900 |
2020/01/15 | 5,810 | 5,830 | 5,810 | 5,820 | +10 | +0.2% | 1,500 |
2020/01/14 | 5,810 | 5,820 | 5,810 | 5,810 | +10 | +0.2% | 1,500 |
2020/01/10 | 5,840 | 5,840 | 5,790 | 5,800 | -30 | -0.5% | 13,000 |
2020/01/09 | 5,820 | 5,830 | 5,820 | 5,830 | +10 | +0.2% | 4,300 |
2020/01/08 | 5,820 | 5,820 | 5,810 | 5,820 | ±0 | ±0% | 3,900 |
2020/01/07 | 5,810 | 5,820 | 5,810 | 5,820 | ±0 | ±0% | 7,500 |
2020/01/06 | 5,810 | 5,850 | 5,810 | 5,820 | -40 | -0.7% | 2,000 |
2019/12/30 | 5,860 | 5,860 | 5,850 | 5,860 | ±0 | ±0% | 900 |
2019/12/27 | 5,830 | 5,860 | 5,830 | 5,860 | +40 | +0.7% | 600 |
2019/12/26 | 5,850 | 5,850 | 5,820 | 5,820 | -10 | -0.2% | 1,800 |
2019/12/25 | 5,800 | 5,830 | 5,800 | 5,830 | +20 | +0.3% | 4,800 |
2019/12/24 | 5,810 | 5,810 | 5,810 | 5,810 | +10 | +0.2% | 2,000 |
1251~
1300
件表示中 / 3684件
類似銘柄と比較する
現在ご覧いただいている「歌舞伎」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
歌舞伎 | 449,500円 | +10.8% | +15.0% | 0.11% | 251.11倍 | 4.82倍 |
|
歌舞伎座の家主。興行は松竹で同社向け劇場賃貸が収益柱。場内外で飲食や物販サービスを提供 |
LINK&M | 52,200円 | +10.0% | +13.7% | 2.99% | 14.33倍 | 4.93倍 |
|
組織・人事・IRなど経営コンサルが主柱。転職支援、資格取得教室や外国語指導講師の派遣も |
フォーラムエンシ | 101,600円 | +10.6% | +34.9% | 4.92% | 19.54倍 | 4.29倍 |
|
機電系エンジニア特化の人材派遣が柱。「コグナビ」ブランド軸にインドでの新卒支援も開始 |
アルプス技 | 264,300円 | +5.7% | +3.5% | 3.56% | 14.02倍 | 2.78倍 |
|
正社員技術者の派遣大手。自動車、電機、電子分野の開発、設計、試作等に強み。職業紹介も |
新日科学 | 126,400円 | +21.0% | -15.9% | 3.96% | 11.96倍 | 1.44倍 |
|
非臨床試験受託の最大手。臨床試験、医療機関支援も展開。米国市場は回復途上。経鼻薬も本腰 |
市場注目の銘柄
チャート関連のコラム